After 2 years, continence, potency, and freedom from recurrence were achieved in almost half of men who had extended pelvic lymph node dissection.
In studies, subsequent use of chemotherapy and concomitant use of abiraterone or enzalutamide did not raise any new safety concerns.
A year after the federal task force came out against routine PSA screening, diagnoses of low-risk PCa decreased by 38% and continued to fall.
TMPRSS2-ERG in peripheral blood mononuclear cells is linked to greater progression risk in men with metastatic CRPC treated with docetaxel.
Biochemical failure rates, however, appear to be better with radiation, single-institution study finds.
Compared with combination treatment, radiation therapy alone was linked with 64% and 83% lower odds of early death and death from cardiac causes among patients with co-existing illnesses.
Findings among veterans flagged for delayed diagnosis of prostate, colorectal cancer.
Rates of adverse pathology varied from 24% for men with more than 2 positive biopsy cores to 45% in men reclassified by Gleason score.
Over 3 years after radical surgery, men who delayed surgery and those who had immediate surgery had similar rates of biochemical recurrence.
This approach is, or should be, the standard of care for locally advanced PCa, some researchers say.
Findings could have implications for active surveillance criteria for African Americans.
Study finds a 66% increased risk of dying from the malignancy in prostate cancer patients with the highest stress levels.
Reduction in prostate-specific antigen level in some patients with biochemical recurrence.
Interview with David F. Penson, MD.
Small study demonstrates the promise of PET-CT using a radiotracer that targets the prostate-specific membrane antigen.
No residual tumor was found in 5.4% of men who received androgen deprivation therapy prior to radical surgery for high-risk prostate cancer.
Men receiving active surveillance were 24 times more likely to die from causes other than prostate cancer over 15 years.
Association found in patients with lymph node involvement.
Advances in prostate cancer screening, management and therapeutics have vastly improved patient care.
Giving docetaxel before abiraterone does not improve progression-free and overall survival compared with the reverse sequence.
Men with PCa have a 4-fold increased risk of suicidal death within 3 months of diagnosis compared to men who have other solid cancers.
This laboratory measure could be useful in treatment decision algorithms.
The technique, with cognitive assistance, identified recurrent tumors in 80% of patients.
PNI in prostate biopsy specimens are associated with an 11-fold increased risk of bone metastasis.
Acupuncture's ability to stimulate endorphin production may partly explain the clinical improvements.
It more accurately predicted the actual clinical risk category at final pathology compared with transrectal ultrasonography-guided biopsy.
A set of genes may identify a prostate cancer subtype in African American patients that needs aggressive treatment.
Surgery for prostate cancer may affect relationship satisfaction among couples, which may ultimately disrupt recovery.
The biochemical recurrence rate after radical prostatectomy is similar to that associated with positive surgical margins.
Compared with laparoscopic radical prostatectomy, robotic-assisted laparoscopic prostatectomy is associated with a 51% increased likelihood of return of erectile function.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)